Garetosmab

Garetosmab (REGN 2477) is A whole-human IgG4 monoclonal antibody that selectively inhibits activin A and acts on COVID-19 44. Garetosmab has potential anti-cancer activity and can be used to study ossifying fibrous dysplasia (FOP) and cancer.

Product Specifications

CAS Number

2097125-54-5

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

TGF-beta/Smad

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CD563302 5 µg

Tissue Genomic DNA, Lung

Ask

View Details

NBP2-42651FR 100 µL

Mouse Monoclonal BMP-2 Antibody (15B3) [DyLight 680]

Ask

View Details

MBS6380724-01 0.1 mL

HABP4 (Intracellular Hyaluronan-binding Protein 4, IHABP-4, IHABP4, Ki-1/57 Intracellular Antigen) (MaxLight 750)

Ask

View Details

MBS6380724-02 5x 0.1 mL

HABP4 (Intracellular Hyaluronan-binding Protein 4, IHABP-4, IHABP4, Ki-1/57 Intracellular Antigen) (MaxLight 750)

Ask

View Details

459316-01 100 mg

N-Methoxy-N-methylpentanamide

Ask

View Details

459316-02 250 mg

N-Methoxy-N-methylpentanamide

Ask

View Details